

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.45371176 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.21108002 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.11364321 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.11364321 |
| 5 | negative T cell selection (GO:0043383) | 5.97083476 |
| 6 | positive thymic T cell selection (GO:0045059) | 5.96215724 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.84333444 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 5.76993304 |
| 9 | negative thymic T cell selection (GO:0045060) | 5.76621576 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.40699323 |
| 11 | positive T cell selection (GO:0043368) | 5.39099583 |
| 12 | negative regulation of cell killing (GO:0031342) | 5.31796729 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.31796729 |
| 14 | thymic T cell selection (GO:0045061) | 5.24065786 |
| 15 | T cell selection (GO:0045058) | 5.07408415 |
| 16 | response to interleukin-15 (GO:0070672) | 4.87098347 |
| 17 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.86980257 |
| 18 | leukocyte aggregation (GO:0070486) | 4.74919042 |
| 19 | tolerance induction (GO:0002507) | 4.60250717 |
| 20 | T cell migration (GO:0072678) | 4.35637246 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.32520164 |
| 22 | cellular response to interleukin-15 (GO:0071350) | 4.31954725 |
| 23 | interferon-gamma production (GO:0032609) | 4.31148570 |
| 24 | regulation of T cell tolerance induction (GO:0002664) | 4.16448904 |
| 25 | T cell receptor signaling pathway (GO:0050852) | 4.15470171 |
| 26 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.15096014 |
| 27 | detection of bacterium (GO:0016045) | 4.08842515 |
| 28 | T cell costimulation (GO:0031295) | 4.05659396 |
| 29 | lymphocyte costimulation (GO:0031294) | 4.00035632 |
| 30 | positive regulation by symbiont of host defense response (GO:0052509) | 3.99536809 |
| 31 | modulation by symbiont of host defense response (GO:0052031) | 3.99536809 |
| 32 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.99536809 |
| 33 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.99536809 |
| 34 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.99536809 |
| 35 | modulation by symbiont of host immune response (GO:0052553) | 3.99536809 |
| 36 | detection of other organism (GO:0098543) | 3.98900620 |
| 37 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.92390369 |
| 38 | response to muramyl dipeptide (GO:0032495) | 3.90567107 |
| 39 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.87867054 |
| 40 | B cell receptor signaling pathway (GO:0050853) | 3.86596853 |
| 41 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.84851154 |
| 42 | regulation of B cell differentiation (GO:0045577) | 3.81182524 |
| 43 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.73134470 |
| 44 | positive regulation of B cell differentiation (GO:0045579) | 3.71169153 |
| 45 | positive regulation of interleukin-2 production (GO:0032743) | 3.71108918 |
| 46 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.64142380 |
| 47 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.64123255 |
| 48 | regulation of regulatory T cell differentiation (GO:0045589) | 3.63318776 |
| 49 | activated T cell proliferation (GO:0050798) | 3.58563514 |
| 50 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.55211152 |
| 51 | positive regulation of tolerance induction (GO:0002645) | 3.53561499 |
| 52 | neutrophil activation involved in immune response (GO:0002283) | 3.50839720 |
| 53 | immunoglobulin mediated immune response (GO:0016064) | 3.46741715 |
| 54 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.46395272 |
| 55 | NIK/NF-kappaB signaling (GO:0038061) | 3.43262935 |
| 56 | T cell homeostasis (GO:0043029) | 3.43178760 |
| 57 | positive regulation of isotype switching (GO:0045830) | 3.39077774 |
| 58 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.31513177 |
| 59 | macrophage activation involved in immune response (GO:0002281) | 3.24450121 |
| 60 | lymphocyte homeostasis (GO:0002260) | 3.22896142 |
| 61 | regulation of granulocyte differentiation (GO:0030852) | 3.20258246 |
| 62 | cellular response to type I interferon (GO:0071357) | 3.18686865 |
| 63 | type I interferon signaling pathway (GO:0060337) | 3.18686865 |
| 64 | leukocyte cell-cell adhesion (GO:0007159) | 3.16814160 |
| 65 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.15912180 |
| 66 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.15586424 |
| 67 | response to peptidoglycan (GO:0032494) | 3.15307380 |
| 68 | negative regulation of innate immune response (GO:0045824) | 3.15157462 |
| 69 | regulation of tolerance induction (GO:0002643) | 3.12885885 |
| 70 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.11786531 |
| 71 | B cell homeostasis (GO:0001782) | 3.11225611 |
| 72 | negative regulation of T cell mediated immunity (GO:0002710) | 3.11033253 |
| 73 | germinal center formation (GO:0002467) | 3.08969182 |
| 74 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.05604859 |
| 75 | positive regulation of granulocyte differentiation (GO:0030854) | 3.05471490 |
| 76 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.05234849 |
| 77 | defense response to protozoan (GO:0042832) | 3.04863342 |
| 78 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.04452285 |
| 79 | respiratory burst (GO:0045730) | 3.03894643 |
| 80 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.03651791 |
| 81 | erythrocyte maturation (GO:0043249) | 3.03612444 |
| 82 | regulation of isotype switching (GO:0045191) | 3.02964002 |
| 83 | natural killer cell differentiation (GO:0001779) | 3.02156133 |
| 84 | myeloid cell activation involved in immune response (GO:0002275) | 2.99823841 |
| 85 | detection of external biotic stimulus (GO:0098581) | 2.96260894 |
| 86 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.96175777 |
| 87 | regulation of response to interferon-gamma (GO:0060330) | 2.94942068 |
| 88 | neutrophil activation (GO:0042119) | 2.93892157 |
| 89 | positive regulation of histone deacetylation (GO:0031065) | 2.92590225 |
| 90 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.91736890 |
| 91 | leukocyte degranulation (GO:0043299) | 2.91690970 |
| 92 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.91193269 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.91149582 |
| 94 | mast cell activation (GO:0045576) | 2.90902817 |
| 95 | regulation of alpha-beta T cell activation (GO:0046634) | 2.90856971 |
| 96 | positive regulation of DNA recombination (GO:0045911) | 2.90404708 |
| 97 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.90092966 |
| 98 | natural killer cell activation (GO:0030101) | 2.89580335 |
| 99 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.89550174 |
| 100 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.88617426 |
| 101 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.88617426 |
| 102 | positive regulation of B cell mediated immunity (GO:0002714) | 2.87623882 |
| 103 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.87623882 |
| 104 | regulation of interleukin-2 production (GO:0032663) | 2.87314574 |
| 105 | negative regulation of interleukin-6 production (GO:0032715) | 2.86465265 |
| 106 | hepatocyte apoptotic process (GO:0097284) | 2.85671352 |
| 107 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.84860233 |
| 108 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.84860233 |
| 109 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.83388691 |
| 110 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.83214467 |
| 111 | positive regulation of humoral immune response (GO:0002922) | 2.82259287 |
| 112 | negative regulation of interleukin-12 production (GO:0032695) | 2.81750537 |
| 113 | negative regulation of phagocytosis (GO:0050765) | 2.80327729 |
| 114 | T cell differentiation (GO:0030217) | 2.80234357 |
| 115 | regulation of B cell mediated immunity (GO:0002712) | 2.78364232 |
| 116 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.76899148 |
| 117 | alpha-beta T cell activation (GO:0046631) | 2.75183938 |
| 118 | positive regulation of immunoglobulin production (GO:0002639) | 2.74449866 |
| 119 | megakaryocyte development (GO:0035855) | 2.74216983 |
| 120 | leukocyte homeostasis (GO:0001776) | 2.73598919 |
| 121 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.73411227 |
| 122 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.72077330 |
| 123 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.72054554 |
| 124 | T cell proliferation (GO:0042098) | 2.71767812 |
| 125 | response to type I interferon (GO:0034340) | 2.71162766 |
| 126 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.71095469 |
| 127 | V(D)J recombination (GO:0033151) | 2.71006923 |
| 128 | cellular extravasation (GO:0045123) | 2.68958544 |
| 129 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.68411695 |
| 130 | Peyers patch development (GO:0048541) | 2.68411695 |
| 131 | myeloid dendritic cell activation (GO:0001773) | 2.68187826 |
| 132 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.67680918 |
| 133 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.66324268 |
| 134 | positive regulation of T cell differentiation (GO:0045582) | 2.61606345 |
| 135 | modulation by virus of host process (GO:0019054) | 2.61406025 |
| 136 | response to protozoan (GO:0001562) | 2.60909797 |
| 137 | positive regulation of B cell activation (GO:0050871) | 2.60035705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.94618540 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.74380566 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.36474485 |
| 4 | * MYC_22102868_ChIP-Seq_BL_Human | 3.93243524 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.57714328 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.05176547 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.00248453 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.96917070 |
| 9 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.69054208 |
| 10 | * MAF_26560356_Chip-Seq_TH1_Human | 2.65779047 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.65715105 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.62320337 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.61054455 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.60359597 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.49457320 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.48874688 |
| 17 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.48555654 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.48469037 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.39769026 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.38408287 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.37515821 |
| 22 | * MYB_26560356_Chip-Seq_TH1_Human | 2.36446272 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.28587436 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.26157734 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.24249198 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.18737504 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13698106 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.00884368 |
| 29 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.00582587 |
| 30 | MAF_26560356_Chip-Seq_TH2_Human | 1.95465048 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95318550 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94980635 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.93886813 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93635287 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.90002882 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86788185 |
| 37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.84520830 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84511746 |
| 39 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.82111438 |
| 40 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.81232784 |
| 41 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.79063555 |
| 42 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.73299116 |
| 43 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72562165 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.66344287 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.65027021 |
| 46 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59741290 |
| 47 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.59267708 |
| 48 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54272647 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.53504032 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53057011 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.53017944 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.52347760 |
| 53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.50579140 |
| 54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.49326445 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47448059 |
| 56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47051727 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46946212 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45497373 |
| 59 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.45004779 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43250397 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39900652 |
| 62 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36933603 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36643636 |
| 64 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.33041200 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31168483 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28570114 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27167080 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26410965 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25039664 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21954530 |
| 71 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19565798 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17937750 |
| 73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12468092 |
| 74 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10891688 |
| 75 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.09527241 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08618266 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07977685 |
| 78 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07813999 |
| 79 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.07077849 |
| 80 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.05832059 |
| 81 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.05217991 |
| 82 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04962949 |
| 83 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03230626 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02729249 |
| 85 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02516632 |
| 86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02101554 |
| 87 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99259548 |
| 88 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99209537 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95696679 |
| 90 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95117406 |
| 91 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.94668833 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94093625 |
| 93 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.93209674 |
| 94 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93019075 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92750580 |
| 96 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92526602 |
| 97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.90959411 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90652721 |
| 99 | * P68_20966046_ChIP-Seq_HELA_Human | 0.88452253 |
| 100 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.86994109 |
| 101 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86956301 |
| 102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86788923 |
| 103 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86763954 |
| 104 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.86323894 |
| 105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84281704 |
| 106 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83113038 |
| 107 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.82609850 |
| 108 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81410929 |
| 109 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.80429749 |
| 110 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80349392 |
| 111 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80144901 |
| 112 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79806012 |
| 113 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.78918642 |
| 114 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78345010 |
| 115 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76702105 |
| 116 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75862644 |
| 117 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.75712441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.18704007 |
| 2 | MP0000685_abnormal_immune_system | 3.59859191 |
| 3 | MP0005671_abnormal_response_to | 3.50063925 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.41361043 |
| 5 | MP0001800_abnormal_humoral_immune | 3.28721153 |
| 6 | MP0001790_abnormal_immune_system | 3.19178773 |
| 7 | MP0005387_immune_system_phenotype | 3.19178773 |
| 8 | MP0002398_abnormal_bone_marrow | 2.84608188 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.68004428 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.65465862 |
| 11 | MP0001873_stomach_inflammation | 2.64499900 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.64223118 |
| 13 | MP0001819_abnormal_immune_cell | 2.61700274 |
| 14 | MP0002723_abnormal_immune_serum | 2.59458051 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.52062138 |
| 16 | MP0003303_peritoneal_inflammation | 2.47784201 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.47474274 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.44661293 |
| 19 | MP0003436_decreased_susceptibility_to | 2.41367804 |
| 20 | MP0000703_abnormal_thymus_morphology | 2.39583631 |
| 21 | MP0002405_respiratory_system_inflammati | 2.37769052 |
| 22 | MP0000716_abnormal_immune_system | 2.37628429 |
| 23 | MP0002722_abnormal_immune_system | 2.35696611 |
| 24 | MP0000689_abnormal_spleen_morphology | 2.33829101 |
| 25 | MP0005025_abnormal_response_to | 2.27416079 |
| 26 | MP0003300_gastrointestinal_ulcer | 2.25582123 |
| 27 | MP0009785_altered_susceptibility_to | 2.19094557 |
| 28 | MP0010155_abnormal_intestine_physiology | 2.16180113 |
| 29 | MP0002429_abnormal_blood_cell | 2.07380152 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 2.06989931 |
| 31 | MP0004947_skin_inflammation | 1.95497149 |
| 32 | MP0003866_abnormal_defecation | 1.91671403 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.89651229 |
| 34 | MP0002006_tumorigenesis | 1.88559907 |
| 35 | MP0004808_abnormal_hematopoietic_stem | 1.87228538 |
| 36 | MP0002419_abnormal_innate_immunity | 1.86528479 |
| 37 | MP0006082_CNS_inflammation | 1.86381344 |
| 38 | MP0004510_myositis | 1.74728758 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.73322148 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.71403335 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.71403335 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.71013918 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.68627006 |
| 44 | MP0009278_abnormal_bone_marrow | 1.53763364 |
| 45 | MP0000490_abnormal_crypts_of | 1.50663329 |
| 46 | MP0001853_heart_inflammation | 1.49081951 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.48503519 |
| 48 | MP0002933_joint_inflammation | 1.45705809 |
| 49 | MP0005310_abnormal_salivary_gland | 1.44263634 |
| 50 | MP0002132_abnormal_respiratory_system | 1.41620980 |
| 51 | MP0003724_increased_susceptibility_to | 1.40031115 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.35119603 |
| 53 | MP0008260_abnormal_autophagy | 1.33657097 |
| 54 | MP0003077_abnormal_cell_cycle | 1.27127790 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.26806187 |
| 56 | MP0000858_altered_metastatic_potential | 1.25843268 |
| 57 | MP0008057_abnormal_DNA_replication | 1.20177261 |
| 58 | MP0003111_abnormal_nucleus_morphology | 1.19790299 |
| 59 | MP0002019_abnormal_tumor_incidence | 1.17827548 |
| 60 | MP0010094_abnormal_chromosome_stability | 1.16351849 |
| 61 | MP0003693_abnormal_embryo_hatching | 1.14482444 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.08227010 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.05567611 |
| 64 | MP0008469_abnormal_protein_level | 1.05420593 |
| 65 | MP0005451_abnormal_body_composition | 1.01341110 |
| 66 | MP0003183_abnormal_peptide_metabolism | 1.01331777 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 0.99484541 |
| 68 | MP0003448_altered_tumor_morphology | 0.97887930 |
| 69 | MP0005174_abnormal_tail_pigmentation | 0.93279660 |
| 70 | MP0001533_abnormal_skeleton_physiology | 0.91682056 |
| 71 | MP0005058_abnormal_lysosome_morphology | 0.91067455 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 0.84876054 |
| 73 | MP0004883_abnormal_blood_vessel | 0.84048358 |
| 74 | MP0010307_abnormal_tumor_latency | 0.83600248 |
| 75 | MP0001663_abnormal_digestive_system | 0.81347280 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 0.80750525 |
| 77 | MP0004957_abnormal_blastocyst_morpholog | 0.79908652 |
| 78 | MP0008961_abnormal_basal_metabolism | 0.78302739 |
| 79 | MP0005023_abnormal_wound_healing | 0.77629655 |
| 80 | MP0001851_eye_inflammation | 0.76195119 |
| 81 | MP0009764_decreased_sensitivity_to | 0.74327720 |
| 82 | MP0003828_pulmonary_edema | 0.72711765 |
| 83 | MP0000313_abnormal_cell_death | 0.72641366 |
| 84 | MP0000350_abnormal_cell_proliferation | 0.72182553 |
| 85 | MP0005166_decreased_susceptibility_to | 0.72161772 |
| 86 | MP0000609_abnormal_liver_physiology | 0.71401314 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.69920232 |
| 88 | MP0004130_abnormal_muscle_cell | 0.68627172 |
| 89 | MP0004381_abnormal_hair_follicle | 0.68535795 |
| 90 | MP0005390_skeleton_phenotype | 0.67209945 |
| 91 | MP0000477_abnormal_intestine_morphology | 0.67021705 |
| 92 | MP0009763_increased_sensitivity_to | 0.65529383 |
| 93 | MP0003566_abnormal_cell_adhesion | 0.64865942 |
| 94 | MP0004147_increased_porphyrin_level | 0.62449600 |
| 95 | MP0000249_abnormal_blood_vessel | 0.61329785 |
| 96 | MP0002009_preneoplasia | 0.60974824 |
| 97 | MP0006054_spinal_hemorrhage | 0.60865577 |
| 98 | MP0003690_abnormal_glial_cell | 0.60809915 |
| 99 | MP0003795_abnormal_bone_structure | 0.58625062 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.58325845 |
| 101 | MP0002693_abnormal_pancreas_physiology | 0.58228488 |
| 102 | MP0009931_abnormal_skin_appearance | 0.58202852 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.57596705 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.57383472 |
| 105 | MP0009840_abnormal_foam_cell | 0.56696073 |
| 106 | MP0008058_abnormal_DNA_repair | 0.55909298 |
| 107 | MP0000604_amyloidosis | 0.54796407 |
| 108 | MP0002254_reproductive_system_inflammat | 0.54657898 |
| 109 | MP0001348_abnormal_lacrimal_gland | 0.53539685 |
| 110 | MP0001730_embryonic_growth_arrest | 0.51482224 |
| 111 | MP0000598_abnormal_liver_morphology | 0.51268047 |
| 112 | MP0005381_digestive/alimentary_phenotyp | 0.50690939 |
| 113 | MP0002998_abnormal_bone_remodeling | 0.50057179 |
| 114 | MP0009115_abnormal_fat_cell | 0.50053985 |
| 115 | MP0002086_abnormal_extraembryonic_tissu | 0.50034108 |
| 116 | MP0005164_abnormal_response_to | 0.49953762 |
| 117 | MP0000015_abnormal_ear_pigmentation | 0.48840874 |
| 118 | MP0008007_abnormal_cellular_replicative | 0.48743221 |
| 119 | MP0005621_abnormal_cell_physiology | 0.48406286 |
| 120 | MP0003045_fibrosis | 0.47991403 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 0.47939860 |
| 122 | MP0008004_abnormal_stomach_pH | 0.47273403 |
| 123 | MP0003075_altered_response_to | 0.46335732 |
| 124 | MP0002928_abnormal_bile_duct | 0.46290673 |
| 125 | MP0008874_decreased_physiological_sensi | 0.45942152 |
| 126 | MP0003091_abnormal_cell_migration | 0.45312725 |
| 127 | MP0005535_abnormal_body_temperature | 0.43726715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.66396039 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.41601484 |
| 3 | Panhypogammaglobulinemia (HP:0003139) | 5.13020513 |
| 4 | IgM deficiency (HP:0002850) | 5.11122723 |
| 5 | Recurrent viral infections (HP:0004429) | 4.79595533 |
| 6 | Recurrent bronchitis (HP:0002837) | 4.67166144 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.64322702 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.57328105 |
| 9 | Abnormality of T cells (HP:0002843) | 4.46403658 |
| 10 | Chronic otitis media (HP:0000389) | 4.27358391 |
| 11 | Abnormality of B cell number (HP:0010975) | 4.25796519 |
| 12 | B lymphocytopenia (HP:0010976) | 4.25796519 |
| 13 | Eczematoid dermatitis (HP:0000976) | 4.15672920 |
| 14 | Abnormality of the fingertips (HP:0001211) | 4.11437460 |
| 15 | Combined immunodeficiency (HP:0005387) | 4.11048829 |
| 16 | Severe combined immunodeficiency (HP:0004430) | 4.08631681 |
| 17 | Nasal polyposis (HP:0100582) | 3.99532139 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.94225512 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.94225512 |
| 20 | Agammaglobulinemia (HP:0004432) | 3.93540445 |
| 21 | Orchitis (HP:0100796) | 3.82863753 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.72084008 |
| 23 | Inflammation of the large intestine (HP:0002037) | 3.71810851 |
| 24 | Gastrointestinal inflammation (HP:0004386) | 3.68568296 |
| 25 | Abnormality of the nasal mucosa (HP:0000433) | 3.46364555 |
| 26 | Meningitis (HP:0001287) | 3.39973875 |
| 27 | IgG deficiency (HP:0004315) | 3.37983256 |
| 28 | Recurrent abscess formation (HP:0002722) | 3.36015506 |
| 29 | Abnormality of T cell physiology (HP:0011840) | 3.35668301 |
| 30 | Lymphopenia (HP:0001888) | 3.30246853 |
| 31 | Thyroiditis (HP:0100646) | 3.29842973 |
| 32 | Colitis (HP:0002583) | 3.27930897 |
| 33 | Recurrent sinusitis (HP:0011108) | 3.24812721 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 3.24269092 |
| 35 | Stomatitis (HP:0010280) | 3.19912299 |
| 36 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.19078005 |
| 37 | Cellulitis (HP:0100658) | 3.13637621 |
| 38 | Eosinophilia (HP:0001880) | 3.07123300 |
| 39 | Prolonged bleeding time (HP:0003010) | 3.04727501 |
| 40 | Papilledema (HP:0001085) | 3.03544047 |
| 41 | Petechiae (HP:0000967) | 2.96818241 |
| 42 | Spontaneous hematomas (HP:0007420) | 2.95537596 |
| 43 | Myositis (HP:0100614) | 2.95109489 |
| 44 | Abnormality of eosinophils (HP:0001879) | 2.88323654 |
| 45 | Gastrointestinal stroma tumor (HP:0100723) | 2.87608881 |
| 46 | Increased IgM level (HP:0003496) | 2.85962792 |
| 47 | Vasculitis (HP:0002633) | 2.85359578 |
| 48 | * Pustule (HP:0200039) | 2.84205169 |
| 49 | * Papilloma (HP:0012740) | 2.83871053 |
| 50 | * Verrucae (HP:0200043) | 2.83871053 |
| 51 | Recurrent skin infections (HP:0001581) | 2.82723895 |
| 52 | Chronic diarrhea (HP:0002028) | 2.80875252 |
| 53 | Recurrent bacterial skin infections (HP:0005406) | 2.80544175 |
| 54 | IgA deficiency (HP:0002720) | 2.79960909 |
| 55 | Granulocytopenia (HP:0001913) | 2.78529113 |
| 56 | Poikilocytosis (HP:0004447) | 2.77142595 |
| 57 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.75854593 |
| 58 | Increased IgE level (HP:0003212) | 2.74458415 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 2.73656921 |
| 60 | Leukocytosis (HP:0001974) | 2.73327265 |
| 61 | Keratoconjunctivitis sicca (HP:0001097) | 2.71480162 |
| 62 | Lymphoma (HP:0002665) | 2.62847686 |
| 63 | Thrombocytosis (HP:0001894) | 2.58719779 |
| 64 | Keratoconjunctivitis (HP:0001096) | 2.56432977 |
| 65 | Epistaxis (HP:0000421) | 2.52591768 |
| 66 | Bronchitis (HP:0012387) | 2.52475479 |
| 67 | Emphysema (HP:0002097) | 2.52270896 |
| 68 | Chronic sinusitis (HP:0011109) | 2.52123053 |
| 69 | Encephalitis (HP:0002383) | 2.49148648 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.46653871 |
| 71 | Obstructive lung disease (HP:0006536) | 2.46653871 |
| 72 | Autoimmune hemolytic anemia (HP:0001890) | 2.45481629 |
| 73 | Hypergammaglobulinemia (HP:0010702) | 2.44371189 |
| 74 | Viral hepatitis (HP:0006562) | 2.38109894 |
| 75 | Hypoplasia of the thymus (HP:0000778) | 2.36820027 |
| 76 | Pulmonary embolism (HP:0002204) | 2.35802994 |
| 77 | Hypochromic anemia (HP:0001931) | 2.35530044 |
| 78 | Abnormal platelet volume (HP:0011876) | 2.35331701 |
| 79 | Hypochromic microcytic anemia (HP:0004840) | 2.32264060 |
| 80 | Joint swelling (HP:0001386) | 2.28895937 |
| 81 | Slow saccadic eye movements (HP:0000514) | 2.25014054 |
| 82 | Recurrent otitis media (HP:0000403) | 2.24671195 |
| 83 | Reticulocytosis (HP:0001923) | 2.17410156 |
| 84 | Acanthocytosis (HP:0001927) | 2.15915264 |
| 85 | Abnormal number of erythroid precursors (HP:0012131) | 2.13207579 |
| 86 | Abnormality of the pleura (HP:0002103) | 2.13065861 |
| 87 | Episodic fever (HP:0001954) | 2.11121138 |
| 88 | Chest pain (HP:0100749) | 2.10727558 |
| 89 | Abnormal platelet function (HP:0011869) | 2.09657510 |
| 90 | Impaired platelet aggregation (HP:0003540) | 2.09657510 |
| 91 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.09390286 |
| 92 | Microcytic anemia (HP:0001935) | 2.08735301 |
| 93 | Anorexia (HP:0002039) | 2.07524572 |
| 94 | Increased density of long bones (HP:0006392) | 2.06432155 |
| 95 | Abnormality of the prostate (HP:0008775) | 2.04975567 |
| 96 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.03748737 |
| 97 | Gastrointestinal infarctions (HP:0005244) | 2.02296003 |
| 98 | Gingival bleeding (HP:0000225) | 2.00089615 |
| 99 | Pulmonary infiltrates (HP:0002113) | 1.99423051 |
| 100 | Hemoptysis (HP:0002105) | 1.98721844 |
| 101 | Sepsis (HP:0100806) | 1.96522873 |
| 102 | Abnormality of reticulocytes (HP:0004312) | 1.96146899 |
| 103 | Restrictive lung disease (HP:0002091) | 1.94712405 |
| 104 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.93217181 |
| 105 | * Skin ulcer (HP:0200042) | 1.93086182 |
| 106 | Periodontitis (HP:0000704) | 1.92815905 |
| 107 | Abnormality of macrophages (HP:0004311) | 1.91543101 |
| 108 | Skin rash (HP:0000988) | 1.91291308 |
| 109 | Premature loss of primary teeth (HP:0006323) | 1.90431799 |
| 110 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.89337909 |
| 111 | Poikiloderma (HP:0001029) | 1.89321035 |
| 112 | Acute hepatic failure (HP:0006554) | 1.89185213 |
| 113 | Stomach cancer (HP:0012126) | 1.89104414 |
| 114 | Arterial thrombosis (HP:0004420) | 1.88830695 |
| 115 | Osteomyelitis (HP:0002754) | 1.87835752 |
| 116 | Gingivitis (HP:0000230) | 1.87502395 |
| 117 | Gangrene (HP:0100758) | 1.86440590 |
| 118 | Glomerulopathy (HP:0100820) | 1.86241177 |
| 119 | Optic neuritis (HP:0100653) | 1.85529960 |
| 120 | Retrobulbar optic neuritis (HP:0100654) | 1.85529960 |
| 121 | Interstitial pulmonary disease (HP:0006530) | 1.85193456 |
| 122 | Urticaria (HP:0001025) | 1.84202291 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.99702313 |
| 2 | PRPF4B | 3.50819261 |
| 3 | TXK | 3.45264444 |
| 4 | STK10 | 2.87010676 |
| 5 | JAK3 | 2.81605384 |
| 6 | GRK6 | 2.81024503 |
| 7 | ZAP70 | 2.76940676 |
| 8 | MAP3K10 | 2.71716813 |
| 9 | EEF2K | 2.48519348 |
| 10 | TYK2 | 2.43778312 |
| 11 | ITK | 2.26852686 |
| 12 | BLK | 2.24121555 |
| 13 | FGFR4 | 2.14109261 |
| 14 | CDK12 | 1.97100082 |
| 15 | SYK | 1.89591585 |
| 16 | MAP3K14 | 1.85450744 |
| 17 | IKBKE | 1.85202550 |
| 18 | BTK | 1.85037049 |
| 19 | JAK1 | 1.62605818 |
| 20 | LCK | 1.59626368 |
| 21 | CSK | 1.54062663 |
| 22 | KDR | 1.53115808 |
| 23 | PASK | 1.45968878 |
| 24 | PKN2 | 1.41502220 |
| 25 | LRRK2 | 1.39580038 |
| 26 | HCK | 1.39498729 |
| 27 | TBK1 | 1.39400073 |
| 28 | FGFR3 | 1.37579510 |
| 29 | TEC | 1.37102489 |
| 30 | SIK2 | 1.36398930 |
| 31 | MARK3 | 1.34584647 |
| 32 | PIM1 | 1.33151035 |
| 33 | NLK | 1.30055974 |
| 34 | TRIB3 | 1.28211554 |
| 35 | NME2 | 1.25236142 |
| 36 | IRAK4 | 1.24456355 |
| 37 | MAP3K13 | 1.21894927 |
| 38 | ERN1 | 1.21052410 |
| 39 | SMG1 | 1.16003356 |
| 40 | IKBKB | 1.14497351 |
| 41 | CSF1R | 1.13448624 |
| 42 | MAP3K7 | 1.12517718 |
| 43 | STK4 | 1.12508498 |
| 44 | NEK2 | 1.11914873 |
| 45 | CLK1 | 1.10545911 |
| 46 | CAMKK1 | 1.08192011 |
| 47 | TGFBR2 | 1.04986212 |
| 48 | EPHB1 | 1.03985052 |
| 49 | JAK2 | 0.99361606 |
| 50 | LYN | 0.97035732 |
| 51 | CAMKK2 | 0.95870991 |
| 52 | CHUK | 0.94815258 |
| 53 | MAP2K3 | 0.94422242 |
| 54 | TNK2 | 0.94412294 |
| 55 | PRKCQ | 0.92735427 |
| 56 | KIT | 0.92216946 |
| 57 | MST4 | 0.91082605 |
| 58 | CDK4 | 0.90096294 |
| 59 | FES | 0.86647378 |
| 60 | MAP3K3 | 0.84612474 |
| 61 | FGR | 0.83673453 |
| 62 | PRKCH | 0.83012669 |
| 63 | TESK2 | 0.82209763 |
| 64 | BRD4 | 0.82025096 |
| 65 | RPS6KA4 | 0.81711163 |
| 66 | MAP3K1 | 0.81635746 |
| 67 | CDC42BPA | 0.77246122 |
| 68 | IRAK3 | 0.71618153 |
| 69 | BMPR2 | 0.70153502 |
| 70 | PTK6 | 0.69363612 |
| 71 | MAP2K2 | 0.67295475 |
| 72 | TAOK1 | 0.66319657 |
| 73 | MAP3K8 | 0.65130144 |
| 74 | TTN | 0.65121973 |
| 75 | ALK | 0.62959689 |
| 76 | CDC7 | 0.60506854 |
| 77 | MAPK11 | 0.59421376 |
| 78 | HIPK2 | 0.56648738 |
| 79 | MELK | 0.56280900 |
| 80 | IRAK1 | 0.54506489 |
| 81 | MAP3K11 | 0.54064588 |
| 82 | YES1 | 0.53874236 |
| 83 | FYN | 0.53352540 |
| 84 | EIF2AK1 | 0.53033446 |
| 85 | FLT3 | 0.52150750 |
| 86 | CDK9 | 0.50431014 |
| 87 | CDK6 | 0.48947935 |
| 88 | TAOK2 | 0.47837054 |
| 89 | SIK1 | 0.47481389 |
| 90 | RPS6KB2 | 0.46162433 |
| 91 | MAPK12 | 0.45777034 |
| 92 | PDK1 | 0.45431545 |
| 93 | PRKD2 | 0.44872929 |
| 94 | RET | 0.43366752 |
| 95 | PDGFRB | 0.43307615 |
| 96 | RPS6KA6 | 0.42726169 |
| 97 | TRPM7 | 0.42231772 |
| 98 | PDPK1 | 0.42102623 |
| 99 | SIK3 | 0.41821246 |
| 100 | STK11 | 0.41788351 |
| 101 | DYRK1B | 0.41276961 |
| 102 | CDK19 | 0.41055868 |
| 103 | KSR2 | 0.40310269 |
| 104 | TGFBR1 | 0.38090212 |
| 105 | CAMK1D | 0.37891783 |
| 106 | MARK2 | 0.37471202 |
| 107 | RPS6KL1 | 0.36761573 |
| 108 | RPS6KC1 | 0.36761573 |
| 109 | MAPK4 | 0.36618326 |
| 110 | MAPKAPK2 | 0.36392284 |
| 111 | TAOK3 | 0.36201911 |
| 112 | EPHA3 | 0.35282507 |
| 113 | MATK | 0.34330285 |
| 114 | PIK3CG | 0.34127274 |
| 115 | MAPK7 | 0.33071345 |
| 116 | CHEK1 | 0.32052241 |
| 117 | RIPK4 | 0.32002199 |
| 118 | TYRO3 | 0.31743172 |
| 119 | ICK | 0.31464289 |
| 120 | CAMK1G | 0.30889432 |
| 121 | RPS6KA5 | 0.30773404 |
| 122 | MAP2K6 | 0.30537661 |
| 123 | STK38 | 0.29593438 |
| 124 | MAPK3 | 0.29426334 |
| 125 | PTK2B | 0.28988330 |
| 126 | TLK1 | 0.28282523 |
| 127 | INSR | 0.28205172 |
| 128 | EGFR | 0.27823219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.60650172 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.13554087 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.66948368 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.64423173 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.61419276 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.48987151 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.45144625 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.40156375 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.38880375 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.38316814 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.14187452 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.11262525 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.06752319 |
| 14 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.76729894 |
| 15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.64770230 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.64326466 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.64150238 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52609065 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.49885869 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.47608445 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.46371752 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.43048339 |
| 23 | Hepatitis B_Homo sapiens_hsa05161 | 1.42084117 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.41496151 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.33543942 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33346840 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32666167 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.29209569 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.25200860 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.21349644 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.20714985 |
| 32 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.20247407 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.19688570 |
| 34 | Ribosome_Homo sapiens_hsa03010 | 1.17100825 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.16158834 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.16018378 |
| 37 | HTLV-I infection_Homo sapiens_hsa05166 | 1.14528777 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.13242433 |
| 39 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.12473626 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10944154 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.08903957 |
| 42 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.06338945 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06125718 |
| 44 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.05484954 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.02196694 |
| 46 | Base excision repair_Homo sapiens_hsa03410 | 1.02027751 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.99186576 |
| 48 | Spliceosome_Homo sapiens_hsa03040 | 0.99163555 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 0.94416683 |
| 50 | Malaria_Homo sapiens_hsa05144 | 0.93661707 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.93345791 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.92839325 |
| 53 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89794871 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88977593 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 0.87709286 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.87249674 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87240292 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85173876 |
| 59 | Mismatch repair_Homo sapiens_hsa03430 | 0.82553375 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81940403 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80391589 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79493575 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78852138 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78696835 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77086633 |
| 66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76861821 |
| 67 | Asthma_Homo sapiens_hsa05310 | 0.75232868 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73871082 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.72628514 |
| 70 | Colorectal cancer_Homo sapiens_hsa05210 | 0.71804750 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71744638 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70735999 |
| 73 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70676315 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69099249 |
| 75 | Cell cycle_Homo sapiens_hsa04110 | 0.66964708 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.66930365 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.65044434 |
| 78 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.64577994 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62811700 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62010727 |
| 81 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60762322 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59970324 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.58943021 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57932409 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57677598 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.54479310 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53304297 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53096630 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52610977 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51749458 |
| 91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50801016 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49760308 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.48452882 |
| 94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47950523 |
| 95 | Homologous recombination_Homo sapiens_hsa03440 | 0.47631264 |
| 96 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46907731 |
| 97 | RNA degradation_Homo sapiens_hsa03018 | 0.46749243 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46617703 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.45321283 |
| 100 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.43394425 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42796612 |
| 102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41277313 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40906417 |
| 104 | RNA transport_Homo sapiens_hsa03013 | 0.40681043 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40588223 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39152524 |
| 107 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38793301 |
| 108 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.37460641 |
| 109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37374038 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.36472967 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36459704 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36240152 |
| 113 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.36201140 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36094379 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34915641 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34822695 |
| 117 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34049255 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32890889 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.32826303 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.32448832 |
| 121 | Lysosome_Homo sapiens_hsa04142 | 0.32310227 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32300395 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.31380535 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30707960 |
| 125 | Long-term potentiation_Homo sapiens_hsa04720 | 0.30014485 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29534409 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27749057 |

